Advertisement
Screener

Canopy Growth Corp (CGC) Operating Expenses

2.8 / 5 stars · 68/120 Roast Me

Canopy Growth Corp Operating Expenses

Canopy Growth Corp (CGC) reported Operating Expenses of CAD 44.35 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2026-08-07

  • Canopy Growth Corp operating expenses for the quarter ending 2026-06-30 was 44.35M CAD, a 9.06% increase year-over-year.
  • Canopy Growth Corp operating expenses for the quarter ending 2026-03-31 was 104.05M CAD, a 261.12% increase year-over-year.
  • Canopy Growth Corp operating expenses for the quarter ending 2025-12-31 was 47.82M CAD, a 0.22% decline year-over-year.
  • Canopy Growth Corp operating expenses for the quarter ending 2025-09-30 was 38.80M CAD, a 42.76% decline year-over-year.
  • Canopy Growth Corp operating expenses for fiscal 2026 was 231.33M CAD, a 17.63% increase from fiscal 2025.
  • Canopy Growth Corp operating expenses for fiscal 2025 was 196.65M CAD, a 36.48% decline from fiscal 2024.
  • Canopy Growth Corp operating expenses for fiscal 2024 was 309.60M CAD, a 87.94% decline from fiscal 2023.
  • Canopy Growth Corp operating expenses for fiscal 2023 was 2.57B CAD, a 208.76% increase from fiscal 2022.
Period endOperating Expenses 3 monthOperating Expenses 3 month as first filedOperating Expenses 6 monthOperating Expenses 6 month as first filedOperating Expenses 9 monthOperating Expenses 9 month as first filedOperating Expenses 12 monthOperating Expenses 12 month as first filed
2026-06-3044.35M CAD
10-Q · filed 2026-08-07
148.40M CAD
derived: sum of 2 quarters · filed 2026-08-07
196.22M CAD
derived: sum of 3 quarters · filed 2026-08-07
235.01M CAD
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31104.05M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15
151.87M CAD
derived: sum of 2 quarters · filed 2026-06-15
190.67M CAD
derived: sum of 3 quarters · filed 2026-06-15
231.33M CAD
10-K · filed 2026-06-15
2025-12-3147.82M CAD
10-Q · filed 2026-02-06
86.61M CAD
derived: sum of 2 quarters · filed 2026-02-06
127.28M CAD
10-Q · filed 2026-02-06
156.09M CAD
derived: sum of 4 quarters · filed 2026-08-07
2025-09-3038.80M CAD
10-Q · filed 2025-11-07
79.46M CAD
10-Q · filed 2025-11-07
108.28M CAD
derived: sum of 3 quarters · filed 2026-08-07
156.19M CAD
derived: sum of 4 quarters · filed 2026-08-07
2025-06-3040.66M CAD
10-Q · filed 2026-08-07
69.48M CAD
derived: sum of 2 quarters · filed 2026-08-07
117.40M CAD
derived: sum of 3 quarters · filed 2026-08-07
185.18M CAD
derived: sum of 4 quarters · filed 2026-08-07
2025-03-3128.81M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15
76.73M CAD
derived: sum of 2 quarters · filed 2026-06-15
144.51M CAD
derived: sum of 3 quarters · filed 2026-06-15
196.65M CAD
10-K · filed 2026-06-15
2024-12-3147.92M CAD
10-Q · filed 2026-02-06
115.70M CAD
derived: sum of 2 quarters · filed 2026-02-06
167.84M CAD
10-Q · filed 2026-02-06
290.05M CAD
derived: sum of 4 quarters · filed 2026-06-15
2024-09-3067.78M CAD
10-Q · filed 2025-11-07
119.92M CAD
10-Q · filed 2025-11-07
242.13M CAD
derived: sum of 3 quarters · filed 2026-06-15
330.67M CAD
derived: sum of 4 quarters · filed 2026-06-15
2024-06-3052.14M CAD
10-Q · filed 2025-08-08
174.35M CAD
derived: sum of 2 quarters · filed 2026-06-15
262.89M CAD
derived: sum of 3 quarters · filed 2026-06-15
293.32M CAD
derived: sum of 4 quarters · filed 2026-06-15
2024-03-31122.21M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15
210.75M CAD
derived: sum of 2 quarters · filed 2026-06-15
241.18M CAD
derived: sum of 3 quarters · filed 2026-06-15
309.60M CAD
10-K · filed 2026-06-15
2023-12-3188.54M CAD
10-Q · filed 2025-02-07
118.97M CAD
derived: sum of 2 quarters · filed 2025-02-07
187.39M CAD
10-Q · filed 2025-02-07
667.84M CAD
derived: sum of 4 quarters · filed 2025-05-30
2023-09-3030.43M CAD
10-Q · filed 2024-11-08
98.85M CAD
10-Q · filed 2024-11-08
579.30M CAD
derived: sum of 3 quarters · filed 2025-05-30
697.22M CAD
derived: sum of 4 quarters · filed 2025-05-30
2023-06-3068.41M CAD
10-Q · filed 2024-08-09
97.28M CAD
10-Q · filed 2023-08-09
548.87M CAD
derived: sum of 2 quarters · filed 2025-05-30
666.79M CAD
derived: sum of 3 quarters · filed 2025-05-30
815.35M CAD
derived: sum of 4 quarters · filed 2025-05-30
2023-03-31480.45M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-30
598.37M CAD
derived: sum of 2 quarters · filed 2025-05-30
746.93M CAD
derived: sum of 3 quarters · filed 2025-05-30
2.57B CAD
10-K · filed 2025-05-30
2.74B CAD
10-K · filed 2023-06-22
2022-12-31117.92M CAD
10-Q · filed 2024-02-09
151.32M CAD
10-Q · filed 2023-02-09
266.48M CAD
derived: sum of 2 quarters · filed 2024-02-09
2.09B CAD
10-Q · filed 2024-02-09
2.17B CAD
10-Q · filed 2023-02-09
2.42B CAD
derived: sum of 4 quarters · filed 2024-05-30
2022-09-30148.56M CAD
10-Q · filed 2023-11-09
179.67M CAD
10-Q · filed 2022-11-09
1.97B CAD
10-Q · filed 2023-11-09
2.02B CAD
10-Q · filed 2022-11-09
2.30B CAD
derived: sum of 3 quarters · filed 2024-05-30
2.46B CAD
derived: sum of 4 quarters · filed 2024-05-30
2022-06-301.84B CAD
10-Q · filed 2023-08-09
2.15B CAD
derived: sum of 2 quarters · filed 2024-05-30
2.31B CAD
derived: sum of 3 quarters · filed 2024-05-30
2.45B CAD
derived: sum of 4 quarters · filed 2024-05-30
2022-03-31312.17M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-30
472.22M CAD
derived: sum of 2 quarters · filed 2024-05-30
616.44M CAD
derived: sum of 3 quarters · filed 2024-05-30
831.38M CAD
10-K · filed 2024-05-30
889.62M CAD
10-K · filed 2022-05-31
2021-12-31160.05M CAD
10-Q · filed 2023-02-09
304.27M CAD
derived: sum of 2 quarters · filed 2023-02-09
519.22M CAD
10-Q · filed 2023-02-09
762.22M CAD
derived: sum of 4 quarters · filed 2023-06-22
2021-09-30144.22M CAD
10-Q · filed 2022-11-09
359.17M CAD
10-Q · filed 2022-11-09
602.17M CAD
derived: sum of 3 quarters · filed 2023-06-22
1.18B CAD
derived: sum of 4 quarters · filed 2023-06-22
2021-06-30214.95M CAD
10-Q · filed 2022-08-09
457.95M CAD
derived: sum of 2 quarters · filed 2023-06-22
1.04B CAD
derived: sum of 3 quarters · filed 2023-06-22
1.35B CAD
derived: sum of 4 quarters · filed 2023-06-22
2021-03-31243.00M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22
821.20M CAD
derived: sum of 2 quarters · filed 2023-06-22
1.13B CAD
derived: sum of 3 quarters · filed 2023-06-22
1.31B CAD
10-K · filed 2023-06-22
2020-12-31578.20M CAD
10-Q · filed 2022-02-09
888.54M CAD
derived: sum of 2 quarters · filed 2022-02-09
1.07B CAD
10-Q · filed 2022-02-09
1.97B CAD
derived: sum of 4 quarters · filed 2022-05-31
2020-09-30310.35M CAD
10-Q · filed 2021-11-08
489.22M CAD
10-Q · filed 2021-11-08
1.39B CAD
derived: sum of 3 quarters · filed 2022-05-31
1.62B CAD
derived: sum of 4 quarters · filed 2022-05-31
2020-06-30178.87M CAD
10-Q · filed 2021-08-06
1.08B CAD
derived: sum of 2 quarters · filed 2022-05-31
1.31B CAD
derived: sum of 3 quarters · filed 2022-05-31
1.58B CAD
derived: sum of 4 quarters · filed 2022-05-31
2020-03-31899.20M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31
1.13B CAD
derived: sum of 2 quarters · filed 2022-05-31
1.40B CAD
derived: sum of 3 quarters · filed 2022-05-31
1.64B CAD
10-K · filed 2022-05-31
2019-12-31230.59M CAD
10-Q · filed 2021-02-09
505.07M CAD
derived: sum of 2 quarters · filed 2021-02-09
738.08M CAD
10-Q · filed 2021-02-09
2019-09-30274.48M CAD
10-Q · filed 2020-11-09
507.49M CAD
10-Q · filed 2020-11-09
2019-06-30233.01M CAD
10-Q · filed 2020-08-10
2019-03-31665.70M CAD
10-K · filed 2021-06-01
2018-03-31152.59M CAD
10-K · filed 2020-06-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87